Adverse Drug Reactions of Different Brands of Ceftazidime Injection
This trial is active, not recruiting.
|Sponsor||National Taiwan University Hospital|
|Start date||March 2001|
|End date||April 2002|
|Trial size||536 participants|
|Trial identifier||NCT00173901, 900104|
The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug.
|Endpoint classification||safety study|
|Intervention model||parallel assignment|
The adverse drug reactions of ceftazidime
The effectiveness of ceftazidime
Male or female participants from 1 year up to 95 years old.
Inclusion Criteria: - patients in surgical intensive care unit who require ceftazidime treatment Exclusion Criteria: - less than 1 year old
|Official title||Adverse Drug Reactions of Different Brands of Ceftazidime Injection|
|Description||Ceftazidime is a third generation cephalosporins that should be reserved for severe bacterial infections. Substitution of the brand ceftazidime with a generic ceftazidime raised some concerns. The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug.|
Call for more information